Teemu Daniel Laajala

Docent (Associate / Adjunct Professor)

University of Turku

Finland

Research Interests

Explore related searches

Professors in Finland Professors in Cancer Biology Cancer Biology professors in Finland

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (8)

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Collaborators (10)

Petra Sipilä

University of Turku

FINLAND

View details

Emmy Verschuren

University of Helsinki

FINLAND

View details

Laura Kohtamäki

University of Helsinki

FINLAND

View details

Jie Bao

University of Helsinki

FINLAND

View details

Federica Eduati

Assistant Professor

Eindhoven University of Technology

NETHERLANDS

View details

Kaisa Joki

University of Turku

FINLAND

View details

Tero Aittokallio

University of Helsinki

FINLAND

View details

Kalle E. Mattila

Helsinki University Hospital

FINLAND

View details

Camilla Böckelman

Helsinki University Hospital

FINLAND

View details

Peter J. Boström

FINLAND

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Teemu Daniel Laajala

Research Interests

Explore related searches

Contact this professor

Articles (8)

A community challenge to predict clinical outcomes after immune checkpoint blockade in non-small cell lung cancer

Low nuclear expression of HIF‐hydroxylases PHD2/EGLN1 and PHD3/EGLN3 are associated with poor recurrence‐free survival in clear cell renal cell carcinoma

OSCAR: Optimal subset cardinality regression using the L0-pseudonorm with applications to prognostic modelling of prostate cancer

Antibiotic Treatment is an Independent Poor Risk Factor in NSCLC But Not in Melanoma Patients Who had Received Anti-PD-1/L1 Monotherapy

High intratumoral dihydrotestosterone is associated with antiandrogen resistance in VCaP prostate cancer xenografts in castrated mice.

Ovarian Cancers with Low CIP2A Tumor Expression Constitute an APR-246–Sensitive Disease Subtype

Androgen Receptor Signaling in Prostate Cancer Genomic Subtypes

A three-feature prediction model for metastasis-free survival after surgery of localized clear cell renal cell carcinoma.

Collaborators (10)

Petra Sipilä

Emmy Verschuren

Laura Kohtamäki

Jie Bao

Federica Eduati

Kaisa Joki

Tero Aittokallio

Kalle E. Mattila

Camilla Böckelman

Peter J. Boström

Make your next move.